Clinical Cancer Research · 2011 · 177 citations · 30 references
MedicineOncologyPharmacologyAutophagyChemotherapyMolecular OncologyAutophagy In CancerAutophagy In DiseaseAutophagy In Stress ResponsesAutophagy PharmacologyAutophagy RegulationCytotoxic ChemotherapyAutophagy ImpairmentAutophagy InhibitionAutophagy PathwayCancer Autophagy PharmacologyHepatocellular Carcinoma PathogenesisTumor ResistanceTumor Suppression MechanismsTumor Suppression Pathways
PURPOSE: Understanding the roles of mammalian autophagy in cancer highlights recent advances in the pharmacologic manipulation of autophagic pathways as a therapeutic strategy for cancer. However, autophagy status and corresponding functions in hepatocellular carcinoma (HCC) after therapeutic stress remain to be clarified. This study was to determine whether the autophagic machinery could be activated after chemotherapy and the contribution of autophagy to tolerance of oxaliplatin in HCC. EXPERIMENTAL DESIGN: Autophagy activation and cell death induced by oxaliplatin were examined in two HCC cell lines as well as in vivo using an HCC model in nude mice. HCC tissue samples with or without locoregional chemotherapy before surgery were also examined by immunohistochemical and electron microscopic analysis. RESULTS: Autophagy was functionally activated in HCC cell lines and xenografts after oxaliplatin treatment. Suppression of autophagy using either pharmacologic inhibitors or RNA interference of essential autophagy gene enhanced cell death induced by oxaliplatin in HCC cells. Generation of reactive oxygen species has an important role in the induction of cell death by oxaliplatin in combination with autophagy inhibitors. Critically, the combination of oxaliplatin with autophagy inhibitor chloroquine resulted in a more pronounced tumor suppression in HCC xenografts. Furthermore, autophagy-specific protein LC3 and autophagic autophagosome formation were induced to a significantly higher level in HCC specimens that had been subjected to locoregional chemotherapy. CONCLUSIONS: Autophagy activation under therapy stress contributes to HCC tumor cell survival. Targeting the autophagy pathway is a promising therapeutic strategy to enhance the effects of chemotherapy and improve clinical outcomes in HCC patients.
30
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Xiao Huan Liang, Saadiya Jackson, Matthew Seaman et al. · Nature · 1999 · 3.3K citations
Autophagy Suppresses Tumorigenesis through Elimination of p62
Robin Mathew, Cristina M. Karp, Brian Beaudoin et al. · Cell · 2009 · 1.7K citations · Full text
Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis
Julian J. Lum, Daniel Bauer, Mei Kong et al. · Cell · 2005 · 1.5K citations · Full text